Euromonitor International
- Item successfully added to cart!
  
  Your cart is empty
  
  Check Out View Cart

Country Report

Consumer Health in

Consumer Health in Switzerland

96 pages, Feb 2019

US$2,650

Add to cart Pay by invoice

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Executive Summary

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Demand drops for consumer health, leading to a weaker performance

Consumer health in Switzerland is recording declining sales, with consumer demand falling steadily and flat value growth for most categories in 2018 – a trend that has been visible since 2016. This is caused by the loss of momentum in the majority of the categories within consumer health, because of product-specific reasons.

High costs force consumers to find ways to save

The health system in Switzerland is one of the best in the world, but it comes at a price to the consumer in the form of high health insurance premiums that add to the household financial burden. Consumers favour prescription medication, as the health insurance premiums cover these, whilst many opt not to take OTC drugs in order to avoid duplicating costs.

Leading brands maintain their top positions

Multinationals, leading European and domestic companies strengthened their positions in consumer health, especially in OTC in 2018, in spite of the waning consumer demand for self-medication per se. This is attributable to the staunch consumer trust in the leading brands that are a staple part of the medicine cabinets of many Swiss households.

Online retailing is hit by stringent legislation

The strict legislation that regulates the online sale of medication has always been challenging in Switzerland. However, a Swiss Federal Court ruling in 2015 against the largest online retailer Apotheke Zur Rose now stipulates that patients need to produce prescriptions from a doctor before online retailers are allowed to dispatch medicine, including OTC drugs.

Consumer health set to see slightly positive improvement over the forecast period

Consumer health in Switzerland is set to see a marginal increase in value sales at constant 2018 prices over the forecast period, compared to overall stagnancy between 2013 and 2018. OTC products are likely to remain at a disadvantage due to a lack of strong innovations to invigorate sales, as the existing strict regulations governing OTC products are not expected to change.

Files are delivered directly into your account within a few minutes of purchase.

Samples

Consumer Health Sample Report Consumer Health Sample Data

Overview

Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Samples: (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Switzerland with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Switzerland, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Switzerland for free:

The Consumer Health in Switzerland market research report includes:

Analysis of key supply-side and demand trends
Detailed segmentation of international and local products
Historic volumes and values, company and brand market shares
Five year forecasts of market trends and market growth
Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

What is the market size of Consumer Health in Switzerland?
What are the major brands in Switzerland?
What are the main trends in OTC Healthcare?

Why buy this report?

Gain competitive intelligence about market leaders
Track key industry trends, opportunities and threats
Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Want to find out more about this report?

Request more information

Consumer Health in Switzerland

EXECUTIVE SUMMARY

Demand drops for consumer health, leading to a weaker performance

High costs force consumers to find ways to save

Leading brands maintain their top positions

Online retailing is hit by stringent legislation

Consumer health set to see slightly positive improvement over the forecast period

MARKET INDICATORS

Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 2 Life Expectancy at Birth 2013-2018

MARKET DATA

Table 3 Sales of Consumer Health by Category: Value 2013-2018
Table 4 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 5 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 6 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2013-2018
Table 8 Distribution of Consumer Health by Format: % Value 2013-2018
Table 9 Distribution of Consumer Health by Format and Category: % Value 2018
Table 10 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

SOURCES

Summary 1 Research Sources

Analgesics in Switzerland

HEADLINES

PROSPECTS

Demand for analgesics drops as consumers become cautious

OTC product maturity reduces consumer demand, but regulation discourages investment in innovation

Swiss consumers favour insurance-covered prescription drugs

COMPETITIVE LANDSCAPE

In spite of falling demand, consumer trust drives growth for leading brands

Small companies more active with innovations

But their future presence in analgesics is threatened by increasing competition

CATEGORY DATA

Table 12 Sales of Analgesics by Category: Value 2013-2018
Table 13 Sales of Analgesics by Category: % Value Growth 2013-2018
Table 14 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2013-2018
Table 15 NBO Company Shares of Analgesics: % Value 2014-2018
Table 16 LBN Brand Shares of Analgesics: % Value 2015-2018
Table 17 Forecast Sales of Analgesics by Category: Value 2018-2023
Table 18 Forecast Sales of Analgesics by Category: % Value Growth 2018-2023

Dermatologicals in Switzerland

HEADLINES

PROSPECTS

Dermatologicals loses momentum as it suffers from a drop in consumer demand

Low price of mass market products attracts consumers

Lack of innovation, competition from mass market products with medicinal properties and cosmeceuticals reduce prospects for dermatologicals

COMPETITIVE LANDSCAPE

Multinationals and large European players continue to lead dermatologicals in 2018, with Bayer at their head

Nestlé subsidiary Galderma Schweiz follows Bayer in highly competitive landscape

Fragmentation in the rest of the competitive landscape

CATEGORY DATA

Table 19 Sales of Dermatologicals by Category: Value 2013-2018
Table 20 Sales of Dermatologicals by Category: % Value Growth 2013-2018
Table 21 NBO Company Shares of Dermatologicals: % Value 2014-2018
Table 22 LBN Brand Shares of Dermatologicals: % Value 2015-2018
Table 23 LBN Brand Shares of Hair Loss Treatments: % Value 2015-2018
Table 24 Forecast Sales of Dermatologicals by Category: Value 2018-2023
Table 25 Forecast Sales of Dermatologicals by Category: % Value Growth 2018-2023

Dermatologicals in Switzerland

HEADLINES

PROSPECTS

Dermatologicals loses momentum as it suffers from a drop in consumer demand

Low price of mass market products attracts consumers

Lack of innovation, competition from mass market products with medicinal properties and cosmeceuticals reduce prospects for dermatologicals

COMPETITIVE LANDSCAPE

Multinationals and large European players continue to lead dermatologicals in 2018, with Bayer at their head

Nestlé subsidiary Galderma Schweiz follows Bayer in highly competitive landscape

Fragmentation in the rest of the competitive landscape

CATEGORY DATA

Table 26 Sales of Dermatologicals by Category: Value 2013-2018
Table 27 Sales of Dermatologicals by Category: % Value Growth 2013-2018
Table 28 NBO Company Shares of Dermatologicals: % Value 2014-2018
Table 29 LBN Brand Shares of Dermatologicals: % Value 2015-2018
Table 30 LBN Brand Shares of Hair Loss Treatments: % Value 2015-2018
Table 31 Forecast Sales of Dermatologicals by Category: Value 2018-2023
Table 32 Forecast Sales of Dermatologicals by Category: % Value Growth 2018-2023

Dietary Supplements in Switzerland

HEADLINES

PROSPECTS

Consumer confidence in dietary supplements diminishes

Minerals benefits from individualisation

As manufacturers generally focus on appealing to modern consumers to stem value loss, minerals looks set to continue seeing higher value growth

COMPETITIVE LANDSCAPE

Fragmentation in dietary supplements competitive landscape

Swiss player Antistress maintains its lead

Limited presence of private label products

CATEGORY DATA

Table 33 Sales of Dietary Supplements by Category: Value 2013-2018
Table 34 Sales of Dietary Supplements by Category: % Value Growth 2013-2018
Table 35 Sales of Dietary Supplements by Positioning: % Value 2013-2018
Table 36 Sales of Fish Oils/Omega Fatty Acids by Type: % Value 2013-2018
Table 37 NBO Company Shares of Dietary Supplements: % Value 2014-2018
Table 38 LBN Brand Shares of Dietary Supplements: % Value 2015-2018
Table 39 Forecast Sales of Dietary Supplements by Category: Value 2018-2023
Table 40 Forecast Sales of Dietary Supplements by Category: % Value Growth 2018-2023

Digestive Remedies in Switzerland

HEADLINES

PROSPECTS

Consumers resort to a healthy lifestyle to tackle digestive illnesses

Maturity and saturation affect sales growth

Low consumer demand and limited distribution expected to deter innovation in this category

COMPETITIVE LANDSCAPE

Leading brands register success even though demand is falling

Probiotic foods are eroding sales for digestive remedies

Leading multinational brands set to maintain their strength, but competition from probiotic products is expected to persist

CATEGORY DATA

Table 41 Sales of Digestive Remedies by Category: Value 2013-2018
Table 42 Sales of Digestive Remedies by Category: % Value Growth 2013-2018
Table 43 NBO Company Shares of Digestive Remedies: % Value 2014-2018
Table 44 LBN Brand Shares of Digestive Remedies: % Value 2015-2018
Table 45 Forecast Sales of Digestive Remedies by Category: Value 2018-2023
Table 46 Forecast Sales of Digestive Remedies by Category: % Value Growth 2018-2023

Eye Care in Switzerland

HEADLINES

PROSPECTS

Low consumer demand affects value growth

Eye health is paramount to Swiss consumers

Modern lifestyles will ensure continuing need for eye care

COMPETITIVE LANDSCAPE

Multinationals lead thanks to strong brands

Small companies face competition from multinationals

Little change expected in the competitive positions

CATEGORY DATA

Table 47 Sales of Eye Care by Category: Value 2013-2018
Table 48 Sales of Eye Care by Category: % Value Growth 2013-2018
Table 49 Sales of Standard Eye Care by Format: % Value 2013-2018
Table 50 Sales of Standard Eye Care by Positioning: % Value 2013-2018
Table 51 NBO Company Shares of Eye Care: % Value 2014-2018
Table 52 LBN Brand Shares of Eye Care: % Value 2015-2018
Table 53 Forecast Sales of Eye Care by Category: Value 2018-2023
Table 54 Forecast Sales of Eye Care by Category: % Value Growth 2018-2023

Herbal/Traditional Products in Switzerland

HEADLINES

PROSPECTS

Herbal medication is used only for minor illnesses

Alternative therapies pose competition

High unit prices and low visibility will also contribute to further slight sales decline over the forecast period

COMPETITIVE LANDSCAPE

Low presence of multinationals in herbal remedies

Strong herbal tradition seen in some categories

Slight value sales decline expected as smaller companies and herbal brands in general continue to compete with standard medication

CATEGORY DATA

Table 55 Sales of Herbal/Traditional Products by Category: Value 2013-2018
Table 56 Sales of Herbal/Traditional Products by Category: % Value Growth 2013-2018
Table 57 NBO Company Shares of Herbal/Traditional Products: % Value 2014-2018
Table 58 LBN Brand Shares of Herbal/Traditional Products: % Value 2015-2018
Table 59 Forecast Sales of Herbal/Traditional Products by Category: Value 2018-2023
Table 60 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2018-2023

Paediatric Consumer Health in Switzerland

HEADLINES

PROSPECTS

Child-specific medication is highly regulated in Switzerland

Parents use OTC medication to treat minor conditions

Parental cautiousness expected to continue restricting category growth

COMPETITIVE LANDSCAPE

The category is fragmented

Restricted market opportunities force companies to withdraw products

Continued product withdrawal expected to lower multinational presence and further limit choices

CATEGORY DATA

Table 61 Sales of Paediatric Consumer Health by Category: Value 2013-2018
Table 62 Sales of Paediatric Consumer Health by Category: % Value Growth 2013-2018
Table 63 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2015-2018
Table 64 NBO Company Shares of Paediatric Consumer Health: % Value 2014-2018
Table 65 LBN Brand Shares of Paediatric Consumer Health: % Value 2015-2018
Table 66 Forecast Sales of Paediatric Consumer Health by Category: Value 2018-2023
Table 67 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2018-2023

Sleep Aids in Switzerland

HEADLINES

PROSPECTS

Stressful lifestyles drive demand for sleep aids

Traditional herbal culture benefits herbal-based products

Perceived as safer, herbal-based products will grow

COMPETITIVE LANDSCAPE

Only the most trusted brands make it to the top

Herbal sleep aids of all kinds perform well but not as well as Valverde

Sleep aids do not attract multinationals

CATEGORY DATA

Table 68 Sales of Sleep Aids: Value 2013-2018
Table 69 Sales of Sleep Aids: % Value Growth 2013-2018
Table 70 NBO Company Shares of Sleep Aids: % Value 2014-2018
Table 71 LBN Brand Shares of Sleep Aids: % Value 2015-2018
Table 72 Forecast Sales of Sleep Aids: Value 2018-2023
Table 73 Forecast Sales of Sleep Aids: % Value Growth 2018-2023

Sleep Aids in Switzerland

HEADLINES

PROSPECTS

Stressful lifestyles drive demand for sleep aids

Traditional herbal culture benefits herbal-based products

Perceived as safer, herbal-based products will grow

COMPETITIVE LANDSCAPE

Only the most trusted brands make it to the top

Herbal sleep aids of all kinds perform well but not as well as Valverde

Sleep aids do not attract multinationals

CATEGORY DATA

Table 74 Sales of Sleep Aids: Value 2013-2018
Table 75 Sales of Sleep Aids: % Value Growth 2013-2018
Table 76 NBO Company Shares of Sleep Aids: % Value 2014-2018
Table 77 LBN Brand Shares of Sleep Aids: % Value 2015-2018
Table 78 Forecast Sales of Sleep Aids: Value 2018-2023
Table 79 Forecast Sales of Sleep Aids: % Value Growth 2018-2023

Sleep Aids in Switzerland

HEADLINES

PROSPECTS

Stressful lifestyles drive demand for sleep aids

Traditional herbal culture benefits herbal-based products

Perceived as safer, herbal-based products will grow

COMPETITIVE LANDSCAPE

Only the most trusted brands make it to the top

Herbal sleep aids of all kinds perform well but not as well as Valverde

Sleep aids do not attract multinationals

CATEGORY DATA

Table 80 Sales of Sleep Aids: Value 2013-2018
Table 81 Sales of Sleep Aids: % Value Growth 2013-2018
Table 82 NBO Company Shares of Sleep Aids: % Value 2014-2018
Table 83 LBN Brand Shares of Sleep Aids: % Value 2015-2018
Table 84 Forecast Sales of Sleep Aids: Value 2018-2023
Table 85 Forecast Sales of Sleep Aids: % Value Growth 2018-2023

Weight Management and Wellbeing in Switzerland

HEADLINES

PROSPECTS

Weight management loses consumer support

Continued sales decline expected for weight loss supplements and OTC obesity

Weight-related problems burden the health system

COMPETITIVE LANDSCAPE

Highly fragmented category

Convenience plays an important role in increasing demand

Low entry barriers set to invite further fragmentation, whilst social media, tabloids expected to increasingly influence trends

CATEGORY DATA

Table 86 Sales of Weight Management and Wellbeing by Category: Value 2013-2018
Table 87 Sales of Weight Management and Wellbeing by Category: % Value Growth 2013-2018
Table 88 NBO Company Shares of Weight Management and Wellbeing: % Value 2014-2018
Table 89 LBN Brand Shares of Weight Management and Wellbeing: % Value 2015-2018
Table 90 Forecast Sales of Weight Management and Wellbeing by Category: Value 2018-2023
Table 91 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2018-2023

Wound Care in Switzerland

HEADLINES

PROSPECTS

Low-value products reduce value growth

Polarisation between low-value items and added-value products

Marginal value growth expected, with value-added products giving wound care a bit of a boost

COMPETITIVE LANDSCAPE

Large value share is in the collective hands of leading multinationals

Basic wound care is in the hands of private label

Private label expected to grow, but not set to become a threat to leading multinational brands

CATEGORY DATA

Table 92 Sales of Wound Care by Category: Value 2013-2018
Table 93 Sales of Wound Care by Category: % Value Growth 2013-2018
Table 94 NBO Company Shares of Wound Care: % Value 2014-2018
Table 95 LBN Brand Shares of Wound Care: % Value 2015-2018
Table 96 Forecast Sales of Wound Care by Category: Value 2018-2023
Table 97 Forecast Sales of Wound Care by Category: % Value Growth 2018-2023

NRT Smoking Cessation Aids in Switzerland

HEADLINES

PROSPECTS

NRT smoking cessation aids loses consumers to new products

The high prices in Switzerland encourage cross-border shopping

NRT smoking cessation aids to face stronger competition from e-cigarettes and other alternatives later in the forecast period

COMPETITIVE LANDSCAPE

High concentration in the category continues

Leading brands offer a wide product range to attract consumers

Convenience is a vital consideration when choosing these products

CATEGORY INDICATORS

Table 98 Number of Smokers by Gender 2013-2018

CATEGORY DATA

Table 99 Sales of NRT Smoking Cessation Aids by Category: Value 2013-2018
Table 100 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2013-2018
Table 101 Sales of NRT Gum by Flavour: % Value 2013-2018
Table 102 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2014-2018
Table 103 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2015-2018
Table 104 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2018-2023
Table 105 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2018-2023

Sports Nutrition in Switzerland

HEADLINES

PROSPECTS

Sports nutrition is a mass market item

Innovative products are key growth drivers

Convenience, wide availability and increasingly higher demand to boost the category over the forecast

COMPETITIVE LANDSCAPE

Leading brands maintain their top rankings

Online retailing is very strong in sports nutrition

Whilst leaders will maintain their positions, competition is set to intensify

CATEGORY DATA

Table 106 Sales of Sports Nutrition by Category: Value 2013-2018
Table 107 Sales of Sports Nutrition by Category: % Value Growth 2013-2018
Table 108 NBO Company Shares of Sports Nutrition: % Value 2014-2018
Table 109 LBN Brand Shares of Sports Nutrition: % Value 2015-2018
Table 110 Forecast Sales of Sports Nutrition by Category: Value 2018-2023
Table 111 Forecast Sales of Sports Nutrition by Category: % Value Growth 2018-2023

Cough, Cold and Allergy (Hay Fever) Remedies in Switzerland

HEADLINES

PROSPECTS

A mild flu season suppresses demand and leads to value stagnation

Easy-to-use products help to drive growth in some categories

Stagnant growth expected over the forecast period

COMPETITIVE LANDSCAPE

High fragmentation creates high competition

Swiss herbal tradition benefits small players

Several new herbal remedies are introduced, but small companies face uncertain future given the intensity of competition

CATEGORY DATA

Table 112 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2013-2018
Table 113 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2013-2018
Table 114 Sales of Decongestants by Category: Value 2013-2018
Table 115 Sales of Decongestants by Category: % Value Growth 2013-2018
Table 116 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2014-2018
Table 117 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2015-2018
Table 118 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2018-2023
Table 119 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2018-2023

Vitamins in Switzerland

HEADLINES

PROSPECTS

Consumers count on a wholesome diet for their vitamin intake

Multivitamins that target specific conditions enjoy momentum

Current consumer preference for a wholesome diet set to continue, further lowering value growth

COMPETITIVE LANDSCAPE

Vitamins is in the hands of three leading companies

Individualisation benefits multinationals

Convenience is a growth driver

CATEGORY DATA

Table 120 Sales of Vitamins by Category: Value 2013-2018
Table 121 Sales of Vitamins by Category: % Value Growth 2013-2018
Table 122 Sales of Multivitamins by Positioning: % Value 2013-2018
Table 123 NBO Company Shares of Vitamins: % Value 2014-2018
Table 124 LBN Brand Shares of Vitamins: % Value 2015-2018
Table 125 Forecast Sales of Vitamins by Category: Value 2018-2023
Table 126 Forecast Sales of Vitamins by Category: % Value Growth 2018-2023

Why buy this report?

Want to find out more about this report?

Request more information

Megatrends

Country Report

Consumer Health in Switzerland

New Report Guarantee

Executive Summary

New Report Guarantee

Demand drops for consumer health, leading to a weaker performance

High costs force consumers to find ways to save

Leading brands maintain their top positions

Online retailing is hit by stringent legislation

Consumer health set to see slightly positive improvement over the forecast period

Samples

Overview

Why buy this report?

Samples: (FAQs about samples):

Want to find out more about this report?

Table of Contents

Consumer Health in Switzerland

EXECUTIVE SUMMARY

Demand drops for consumer health, leading to a weaker performance

High costs force consumers to find ways to save

Leading brands maintain their top positions

Online retailing is hit by stringent legislation

Consumer health set to see slightly positive improvement over the forecast period

MARKET INDICATORS

MARKET DATA

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

SOURCES

Analgesics in Switzerland

HEADLINES

PROSPECTS

Demand for analgesics drops as consumers become cautious

OTC product maturity reduces consumer demand, but regulation discourages investment in innovation

Swiss consumers favour insurance-covered prescription drugs

COMPETITIVE LANDSCAPE

In spite of falling demand, consumer trust drives growth for leading brands

Small companies more active with innovations

But their future presence in analgesics is threatened by increasing competition

CATEGORY DATA

Dermatologicals in Switzerland

HEADLINES

PROSPECTS

Dermatologicals loses momentum as it suffers from a drop in consumer demand

Low price of mass market products attracts consumers

Lack of innovation, competition from mass market products with medicinal properties and cosmeceuticals reduce prospects for dermatologicals

COMPETITIVE LANDSCAPE

Multinationals and large European players continue to lead dermatologicals in 2018, with Bayer at their head

Nestlé subsidiary Galderma Schweiz follows Bayer in highly competitive landscape

Fragmentation in the rest of the competitive landscape

CATEGORY DATA

Dermatologicals in Switzerland

HEADLINES

PROSPECTS

Dermatologicals loses momentum as it suffers from a drop in consumer demand

Low price of mass market products attracts consumers

Lack of innovation, competition from mass market products with medicinal properties and cosmeceuticals reduce prospects for dermatologicals

COMPETITIVE LANDSCAPE

Multinationals and large European players continue to lead dermatologicals in 2018, with Bayer at their head

Nestlé subsidiary Galderma Schweiz follows Bayer in highly competitive landscape

Fragmentation in the rest of the competitive landscape

CATEGORY DATA

Dietary Supplements in Switzerland

HEADLINES

PROSPECTS

Consumer confidence in dietary supplements diminishes

Minerals benefits from individualisation

As manufacturers generally focus on appealing to modern consumers to stem value loss, minerals looks set to continue seeing higher value growth

COMPETITIVE LANDSCAPE

Fragmentation in dietary supplements competitive landscape

Swiss player Antistress maintains its lead

Limited presence of private label products

CATEGORY DATA

Digestive Remedies in Switzerland

HEADLINES

PROSPECTS

Consumers resort to a healthy lifestyle to tackle digestive illnesses